InVivo in the News
Published: October 16, 2014
FDA News Device Daily Bulletin InVivo Therapeutics said Tuesday it has enrolled the first patient in a pilot study of the Neuro-Spinal Scaffold. The device is being evaluated as a treatment for complete traumatic spinal cord injuries. The study — conducted at St. Joseph’s Hospital and Medical Center in Phoenix, Ariz. — will gauge the safety and preliminary efficacy of the scaffold, determined by no worsening of paralysis or sensory motor neurological function, the company said.View Article
The articles contained in this section of the website are written and published by persons not affiliated with InVivo. The views expressed in these articles are those of the author(s) and do not reflect the views of InVivo. Additionally, the information contained in these articles may not be current. InVivo disclaims any obligation to correct or to update the information contained in these articles.